Some cancer tumours 'immune to common chemotherapy'

28 March 2012

Some breast cancer tumours may be able to fight off the effects of chemotherapy treatment, new research has found.

A team of scientists at the University of Alberta have been successful in discovering tumours which contained low levels of certain genes.

Due to this design, the tumours did not respond too well when subjected to taxane chemotherapy, a common treatment for thwarting breast cancer development.

Ing Swie Goping, a principal investigator of the research, commented: "These tumours didn't shrink and were resistant to a common chemotherapy treatment. These results give us a strong incentive to continue our research."

The researchers are now set to examine further tumour samples from thousands of patients over the next few years in order to enhance taxane chemotherapy treatments.

Recently, scientists from Queen Mary, University of London, discovered that the cancer gene FOXM1 has the ability to 'brainwash' normal cells so that they inhabit characteristics usually associated with cancerous ones.

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)